Menu
GeneBe

ANTXR2

ANTXR cell adhesion molecule 2

Basic information

Region (hg38): 4:79901145-80125454

Links

ENSG00000163297NCBI:118429OMIM:608041HGNC:21732Uniprot:P58335AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hyaline fibromatosis syndrome (Strong), mode of inheritance: AR
  • juvenile hyaline fibromatosis (Supportive), mode of inheritance: AR
  • infantile systemic hyalinosis (Supportive), mode of inheritance: AR
  • hyaline fibromatosis syndrome (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hyaline fibromatosis syndromeARAllergy/Immunology/Infectious; Dermatologic; MusculoskeletalThe condition may be clinically recognizable, but involves manifestations that require clinical care, such as fracture susceptibility, intractable diarrhea, and infection susceptibility, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficialAllergy/Immunology/Infectious; Dental; Dermatologic; Gastrointestinal; Musculoskeletal20896407; 20896998; 55105; 2434938; 2433666; 3544844; 487969; 11206353; 12214284; 11298373; 12973667; 14508707

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ANTXR2 gene.

  • Hyaline fibromatosis syndrome (168 variants)
  • not provided (72 variants)
  • Inborn genetic diseases (18 variants)
  • not specified (8 variants)
  • ANTXR2-related condition (1 variants)
  • Central core myopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANTXR2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
3
clinvar
4
clinvar
8
missense
2
clinvar
3
clinvar
35
clinvar
4
clinvar
2
clinvar
46
nonsense
1
clinvar
1
clinvar
1
clinvar
3
start loss
1
clinvar
1
frameshift
7
clinvar
4
clinvar
11
inframe indel
0
splice donor/acceptor (+/-2bp)
5
clinvar
5
splice region
4
3
2
9
non coding
85
clinvar
22
clinvar
46
clinvar
153
Total 10 13 123 29 52

Highest pathogenic variant AF is 0.000132

Variants in ANTXR2

This is a list of pathogenic ClinVar variants found in the ANTXR2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-79901668-T-C Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)905310
4-79901827-G-C Hyaline fibromatosis syndrome Benign (Jan 13, 2018)905311
4-79901882-A-G Hyaline fibromatosis syndrome Benign (Jan 13, 2018)905312
4-79901902-T-C Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)905313
4-79901904-C-T Hyaline fibromatosis syndrome Uncertain significance (Jan 12, 2018)905314
4-79901905-G-A Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)905315
4-79902004-C-T Hyaline fibromatosis syndrome Likely benign (Jan 13, 2018)906916
4-79902016-T-C Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)906917
4-79902071-T-C Hyaline fibromatosis syndrome Uncertain significance (Mar 30, 2018)906918
4-79902119-A-C Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)906919
4-79902163-T-G Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)906920
4-79902206-C-A Hyaline fibromatosis syndrome Likely benign (Jan 13, 2018)906921
4-79902512-C-T Hyaline fibromatosis syndrome Uncertain significance (Jan 12, 2018)906922
4-79902573-G-A Hyaline fibromatosis syndrome Likely benign (Jan 12, 2018)906923
4-79902582-G-A Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)907902
4-79902717-G-A Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)907903
4-79902726-A-T Hyaline fibromatosis syndrome Uncertain significance (Jan 12, 2018)907904
4-79902761-A-G Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)907905
4-79902799-T-A Hyaline fibromatosis syndrome Likely benign (Jan 13, 2018)907906
4-79902853-T-C Hyaline fibromatosis syndrome Uncertain significance (Jan 13, 2018)907907
4-79902925-G-A Hyaline fibromatosis syndrome Uncertain significance (Jan 12, 2018)907908
4-79902967-T-C Hyaline fibromatosis syndrome Uncertain significance (Jan 12, 2018)907909
4-79903097-C-T Hyaline fibromatosis syndrome Uncertain significance (Mar 30, 2018)904597
4-79903157-G-A Hyaline fibromatosis syndrome Benign (Jan 13, 2018)904598
4-79903165-A-T Hyaline fibromatosis syndrome Uncertain significance (Jan 12, 2018)904599

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ANTXR2protein_codingprotein_codingENST00000307333 16224306
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.08690.9131246070291246360.000116
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.031912350.8120.00001183083
Missense in Polyphen6493.8210.682151254
Synonymous0.6067582.00.9150.00000407946
Loss of Function3.47726.10.2680.00000124362

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003590.000351
Ashkenazi Jewish0.0001010.0000994
East Asian0.0001140.000111
Finnish0.000.00
European (Non-Finnish)0.0001650.000159
Middle Eastern0.0001140.000111
South Asian0.00003410.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Necessary for cellular interactions with laminin and the extracellular matrix. {ECO:0000269|PubMed:11683410, ECO:0000269|PubMed:12973667}.;
Disease
DISEASE: Hyaline fibromatosis syndrome (HFS) [MIM:228600]: An autosomal recessive syndrome characterized by abnormal growth of hyalinized fibrous tissue usually affecting subcutaneous regions on the scalp, ears, neck, face, hands, and feet. The lesions appear as pearly papules or fleshy nodules. Additional features include gingival hypertrophy, progressive joint contractures resulting in severe limitation of mobility, osteopenia, and osteoporosis. Disease severity is variable. Some individuals manifest symptoms in infancy and have additional visceral or systemic involvement. Hyaline deposits in multiple organs, recurrent infections and intractable diarrhea often lead to early death. Surviving children may suffer from severely reduced mobility due to joint contractures. Other patients have later onset of a milder disorder affecting only the face and digits. {ECO:0000269|PubMed:12973667, ECO:0000269|PubMed:14508707, ECO:0000269|PubMed:15725249}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
NOD-like receptor signaling pathway - Homo sapiens (human);Disease;Uptake and actions of bacterial toxins;Uptake and function of anthrax toxins;Infectious disease;Cellular roles of Anthrax toxin (Consensus)

Recessive Scores

pRec
0.109

Intolerance Scores

loftool
0.540
rvis_EVS
0.57
rvis_percentile_EVS
82.08

Haploinsufficiency Scores

pHI
0.297
hipred
N
hipred_score
0.465
ghis
0.434

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.669

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Antxr2
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
antxr2a
Affected structure
anterior neural plate
Phenotype tag
abnormal
Phenotype quality
increased width

Gene ontology

Biological process
reproductive process;toxin transport
Cellular component
extracellular region;endoplasmic reticulum membrane;plasma membrane;external side of plasma membrane;cell surface;endosome membrane;integral component of membrane
Molecular function
transmembrane signaling receptor activity;protein binding;metal ion binding